Oncolix Inc. (fka ONCX)

[GR8 Dad]

Hey jimbo a couple of things: 1st the prolsnta study apears to date back to 2018 in January which means that the study is over 3 years old in phase 1. Do you have any information of phase 2 studies or phase 1 results or any updates of that nature?

2nd oncx is suggesting prolanta is a monotherapy or combination therapy for a host of horrible cancers. If this becomes a monotherapy read Cure. I think that this would be a $30 to $40 per share stock.

However everything here is a long shot with a skull and crossbones and dated phase one study with no available results of which I am aware.

As always good luck in your trades.